# FDA recall D-1149-2023

> **VistaPharm LLC** · Class II · drug recall initiated 2023-08-30.

## Product

Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16

## Reason for recall

Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results

## Distribution

Distributed nationwide to 68 consignees in the U.S.

## Key facts

- **Recall number:** D-1149-2023
- **Recalling firm:** VistaPharm LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-08-30
- **Report date:** 2023-09-20
- **Termination date:** 2024-07-26

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Largo, FL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1149-2023

## Citation

> AI Analytics. FDA recall D-1149-2023. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-1149-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*